Abstract

BackgroundChronic kidney disease (CKD) is a known risk factor for cardiovascular events and all-cause mortality. We investigate the relationship between CKD stage, proteinuria, hypertension and these adverse outcomes in the people with diabetes. We also study the outcomes of people who did not have monitoring of renal function.MethodsA cohort of people with type 1 and 2 diabetes (N = 35,502) from the Quality Improvement in Chronic Kidney Disease (QICKD) cluster randomised trial was followed up over 2.5 years. A composite of all-cause mortality, cardiovascular events, and end stage renal failure comprised the outcome measure. A multilevel logistic regression model was used to determine correlates with this outcome. Known cardiovascular and renal risk factors were adjusted for.ResultsProteinuria and reduced estimated glomerular filtration rate (eGFR) were independently associated with adverse outcomes in people with diabetes. People with an eGFR <60 ml/min, proteinuria, and hypertension have the greatest odds ratio (OR) of adverse outcome; 1.58 (95% CI 1.36-1.83). Renal function was not monitored in 4460 (12.6%) people. Unmonitored renal function was associated with adverse events; OR 1.35 (95% CI 1.13-1.63) in people with hypertension and OR 1.32 (95% CI 1.07-1.64) in those without.ConclusionsProteinuria, eGFR < 60 ml/min, and failure to monitor renal function are associated with cardiovascular and renal events and mortality in people with diabetes.

Highlights

  • Chronic kidney disease (CKD) is a known risk factor for cardiovascular events and all-cause mortality

  • We investigated the association of estimated glomerular filtration rate (eGFR) and proteinuria on adverse vascular and renal outcomes in people with diabetes, with or without hypertension, in a community setting

  • In addition we investigated the association of these outcomes in people who did not have monitoring of their renal function

Read more

Summary

Introduction

Chronic kidney disease (CKD) is a known risk factor for cardiovascular events and all-cause mortality. We investigate the relationship between CKD stage, proteinuria, hypertension and these adverse outcomes in the people with diabetes. Chronic kidney disease (CKD) is a risk factor for cardiovascular disease and mortality both in the general population [4,5] and amongst people with diabetes [6]. Identification of CKD and intervention with renoprotective measures, the use of angiotensin converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), has been shown to be effective in slowing progression of renal disease and in reducing cardiovascular events [12,13,14,15,16], and treatment that reduces proteinuria reduces the risk of progression [17]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call